{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:06:33Z","timestamp":1791353193684,"version":"4.3.1"},"reference-count":127,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196322","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T17:31:17Z","timestamp":1525973477000},"page":"e0196322","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas"],"prefix":"10.1371","volume":"13","author":[{"given":"Elsje","family":"Pienaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Linderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-2591","authenticated-orcid":true,"given":"Denise E.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"ref1","unstructured":"WHO. Global tuberculosis report. 2016."},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"CE Barry 3rd","year":"2009","journal-title":"Nature reviews Microbiology"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis","volume":"63","author":"P Nahid","year":"2016","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"H Getahun","year":"2015","journal-title":"Eur Respir J"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","article-title":"Isoniazid preventive therapy and risk for resistant tuberculosis","volume":"12","author":"ME Balcells","year":"2006","journal-title":"Emerging infectious diseases"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/595689","article-title":"Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis","volume":"48","author":"A Cattamanchi","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"PL Lin","year":"2014","journal-title":"Nature medicine"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"PL Lin","year":"2009","journal-title":"Infection and immunity"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.05208-11","article-title":"Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions","volume":"56","author":"MC Kjellsson","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jtbi.2014.11.021","article-title":"A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment","volume":"367","author":"E Pienaar","year":"2015","journal-title":"J Theor Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12918-015-0221-8","article-title":"In silico evaluation and exploration of antibiotic tuberculosis treatment regimens","volume":"9","author":"E Pienaar","year":"2015","journal-title":"BMC systems biology"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin","volume":"51","author":"T Gumbo","year":"2007","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0962-8479(95)90016-0","article-title":"Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema","volume":"76","author":"AM Elliott","year":"1995","journal-title":"Tuber Lung Dis"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QCO.0b013e3283462362","article-title":"Contribution of mathematical modeling to the fight against bacterial antibiotic resistance","volume":"24","author":"L Opatowski","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"ref15","article-title":"Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study","author":"A Sharma","year":"2017","journal-title":"The Lancet Infectious diseases"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"EA Kendall","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"9223","key":"ref17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(00)02429-6","article-title":"Classification of drug-resistant tuberculosis in an epidemic area","volume":"356","author":"A Van Rie","year":"2000","journal-title":"Lancet"},{"key":"ref18","article-title":"Handbook of Antimicrobial Resistance","author":"FA Khan","year":"2017"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2012.02.021","article-title":"Outwitting evolution: fighting drug-resistant TB, malaria, and HIV","volume":"148","author":"DE Goldberg","year":"2012","journal-title":"Cell"},{"key":"ref20","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","author":"K Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015","volume":"19","author":"Y Zhang","year":"2015","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"e1001880","DOI":"10.1371\/journal.pmed.1001880","article-title":"Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal","volume":"12","author":"KA Cohen","year":"2015","journal-title":"PLoS medicine"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nm1110","article-title":"Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness","volume":"10","author":"T Cohen","year":"2004","journal-title":"Nature medicine"},{"issue":"12","key":"ref24","first-page":"1456","article-title":"Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis","volume":"13","author":"S Borrell","year":"2009","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40265-014-0248-y","article-title":"Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy","volume":"74","author":"A Trauner","year":"2014","journal-title":"Drugs"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities","volume":"2","author":"C Vilcheze","year":"2014","journal-title":"Microbiol Spectr"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights","volume":"8","author":"JM Musser","year":"1995","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AEM.20.5.810-814.1970","article-title":"Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis","volume":"20","author":"HL David","year":"1970","journal-title":"Applied microbiology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0092-8674(03)00270-8","article-title":"DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis","volume":"113","author":"HI Boshoff","year":"2003","journal-title":"Cell"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/JCM.41.4.1520-1524.2003","article-title":"Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate","volume":"41","author":"J Werngren","year":"2003","journal-title":"Journal of clinical microbiology"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkt364","article-title":"Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis","volume":"69","author":"M McGrath","year":"2014","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ng.2656","article-title":"Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis","volume":"45","author":"CB Ford","year":"2013","journal-title":"Nature genetics"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"e1000034","DOI":"10.1371\/journal.ppat.1000034","article-title":"The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis","volume":"4","author":"M Caws","year":"2008","journal-title":"PLoS pathogens"},{"issue":"5782","key":"ref34","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","author":"S Gagneux","year":"2006","journal-title":"Science"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","article-title":"Mutations of Bacteria from Virus Sensitivity to Virus Resistance","volume":"28","author":"SE Luria","year":"1943","journal-title":"Genetics"},{"issue":"23","key":"ref36","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1073\/pnas.1400352111","article-title":"Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections","volume":"111","author":"P Ankomah","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"e1002487","DOI":"10.1371\/journal.ppat.1002487","article-title":"Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum","volume":"8","author":"P Ankomah","year":"2012","journal-title":"PLoS pathogens"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.41.2.363","article-title":"The population dynamics of antimicrobial chemotherapy","volume":"41","author":"M Lipsitch","year":"1997","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref39","first-page":"187","article-title":"Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance","volume":"2","author":"M Lipsitch","year":"1998","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"ref40","first-page":"265","article-title":"Bacterial evolution and the cost of antibiotic resistance","volume":"1","author":"RE Lenski","year":"1998","journal-title":"Int Microbiol"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrg2778","article-title":"The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts","volume":"11","author":"RC MacLean","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"Suppl 3","key":"ref42","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1086\/321843","article-title":"Minimizing potential resistance: a population dynamics view","volume":"33","author":"BR Levin","year":"2001","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0040-5809(87)90053-0","article-title":"Antibiotic exposure and resistance in mixed bacterial populations","volume":"32","author":"AM Garber","year":"1987","journal-title":"Theoretical population biology"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/imammb\/dql026","article-title":"Within-host population dynamics of antibiotic-resistant M. tuberculosis","volume":"24","author":"J Alavez-Ramirez","year":"2007","journal-title":"Math Med Biol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jtbi.2009.09.002","article-title":"A network-based approach for resistance transmission in bacterial populations","volume":"262","author":"R Gehring","year":"2010","journal-title":"J Theor Biol"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"e18327","DOI":"10.1371\/journal.pone.0018327","article-title":"Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy","volume":"6","author":"C Colijn","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"SH Gillespie","year":"2002","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tim.2017.07.005","article-title":"Phagocytes, Antibiotics, and Self-Limiting Bacterial Infections","volume":"25","author":"BR Levin","year":"2017","journal-title":"Trends in microbiology"},{"key":"ref49","article-title":"Radiologic responses in cynomolgous macaques for assessing tuberculosis chemotherapy regimens","author":"PL Lin","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"35","key":"ref50","doi-asserted-by":"crossref","first-page":"14188","DOI":"10.1073\/pnas.1121497109","article-title":"Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques","volume":"109","author":"PL Lin","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ref51","doi-asserted-by":"crossref","first-page":"e68680","DOI":"10.1371\/journal.pone.0068680","article-title":"Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection","volume":"8","author":"NA Cilfone","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1003299","article-title":"Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation","volume":"186","author":"M Fallahi-Sichani","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.4049\/jimmunol.0802297","article-title":"Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection","volume":"182","author":"JC Ray","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jtbi.2004.06.031","article-title":"Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model","volume":"231","author":"JL Segovia-Juarez","year":"2004","journal-title":"J Theor Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4614-6111-1_12","article-title":"The role of B cells and humoral immunity in Mycobacterium tuberculosis infection","volume":"783","author":"L Kozakiewicz","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tube.2013.09.004","article-title":"Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis","volume":"94","author":"E Marzo","year":"2014","journal-title":"Tuberculosis"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4049\/jimmunol.1400734","article-title":"Computational modeling predicts interleukin-10 control of lesion sterilization by balancing early host-immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection","volume":"194","author":"NA Cilfone","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/IAI.01438-15","article-title":"Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions","volume":"84","author":"E Pienaar","year":"2016","journal-title":"Infection and immunity"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/wsbm.1270","article-title":"Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models","volume":"6","author":"DE Kirschner","year":"2014","journal-title":"Wiley interdisciplinary reviews Systems biology and medicine"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"LE Via","year":"2008","journal-title":"Infection and immunity"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/IAI.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"LG Wayne","year":"1996","journal-title":"Infection and immunity"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00044011-199611040-00006","article-title":"Dosage Regimens of Antibacterials","volume":"11","author":"MY Bouvier d\u2019Yvoire","year":"1996","journal-title":"Clin Drug Invest"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2215\/CJN.03960609","article-title":"Review on pharmacokinetics and pharmacodynamics and the aging kidney","volume":"5","author":"C Aymanns","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"CB Ford","year":"2011","journal-title":"Nature genetics"},{"issue":"7","key":"ref65","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/AAC.00474-12","article-title":"Induction of mycobacterial resistance to quinolone class antimicrobials","volume":"56","author":"M Malik","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.20151248","article-title":"Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo","volume":"213","author":"Y Liu","year":"2016","journal-title":"J Exp Med"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mib.2006.12.007","article-title":"Microbial phenotypic heterogeneity and antibiotic tolerance","volume":"10","author":"N Dhar","year":"2007","journal-title":"Current opinion in microbiology"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2014.11.016","article-title":"Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms","volume":"17","author":"G Manina","year":"2015","journal-title":"Cell host & microbe"},{"issue":"6064","key":"ref69","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1216166","article-title":"Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility","volume":"335","author":"BB Aldridge","year":"2012","journal-title":"Science"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0031-2013","article-title":"The Spectrum of Drug Susceptibility in Mycobacteria","volume":"2","author":"BB Aldridge","year":"2014","journal-title":"Microbiol Spectr"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/AAC.06460-11","article-title":"Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis","volume":"56","author":"L Fenner","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"e34538","DOI":"10.1371\/journal.pone.0034538","article-title":"Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis","volume":"7","author":"D Machado","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/jinf.2000.0711","article-title":"Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment","volume":"41","author":"AP Davies","year":"2000","journal-title":"J Infect"},{"issue":"Suppl 1","key":"ref74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1469-0691.2008.02685.x","article-title":"Fitness cost of drug resistance in Mycobacterium tuberculosis","volume":"15","author":"S Gagneux","year":"2009","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/AAC.48.4.1289-1294.2004","article-title":"Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis","volume":"48","author":"DH Mariam","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkp262","article-title":"Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis","volume":"64","author":"T Schon","year":"2009","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tig.2012.11.005","article-title":"The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"29","author":"B Muller","year":"2013","journal-title":"Trends in genetics: TIG"},{"issue":"297","key":"ref78","doi-asserted-by":"crossref","first-page":"297ra114","DOI":"10.1126\/scitranslmed.aab1621","article-title":"Fitness cost of antibiotic susceptibility during bacterial infection","volume":"7","author":"D Roux","year":"2015","journal-title":"Science translational medicine"},{"issue":"6","key":"ref79","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1469-0691.2011.03556.x","article-title":"Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis","volume":"17","author":"S Borrell","year":"2011","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"ref80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2958.2012.08099.x","article-title":"Fitness-compensatory mutations in rifampicin-resistant RNA polymerase","volume":"85","author":"G Brandis","year":"2012","journal-title":"Molecular microbiology"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.01541-12","article-title":"Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission","volume":"57","author":"M de Vos","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5268","key":"ref82","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.272.5268.1641","article-title":"Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis","volume":"272","author":"DR Sherman","year":"1996","journal-title":"Science"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"e1004857","DOI":"10.1371\/journal.pcbi.1004857","article-title":"Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment","volume":"12","author":"E Gjini","year":"2016","journal-title":"PLoS computational biology"},{"issue":"2","key":"ref84","first-page":"313","article-title":"Drug resistance among previously treated tuberculosis patients, a brief report","volume":"121","author":"HD Costello","year":"1980","journal-title":"The American review of respiratory disease"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0041-3879(64)80080-5","article-title":"Resistance of Tubercle Bacilli to Isoniazid, Pas and Streptomycin, Related to History of Previous Treatment","volume":"45","author":"DH Shennan","year":"1964","journal-title":"Tubercle"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/jama.1963.03060010032004","article-title":"Increased resistance of Mycobacterium tuberculosis to drug therapy. A study of the frequency of drug-resistant tubercle bacilli among 482 patients and its effect on recovery","volume":"185","author":"E Gerszten","year":"1963","journal-title":"JAMA"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0041-3879(64)80064-7","article-title":"Drug-Resistance in Patients with Pulmonary Tuberculosis Presenting at Chest Clinics in Hong Kong","volume":"45","author":"A Pines","year":"1964","journal-title":"Tubercle"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0041-3879(60)80060-8","article-title":"Bacterial resistance to streptomycin, PAS and isoniazid in untreated patients with symptomatic pulmonary tuberculosis in Ashanti","volume":"41","author":"WJ Bell","year":"1960","journal-title":"Tubercle"},{"issue":"4","key":"ref89","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.0306407101","article-title":"T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node","volume":"101","author":"MJ Miller","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"S Marino","year":"2008","journal-title":"J Theor Biol"},{"issue":"2","key":"ref91","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"A Sandgren","year":"2009","journal-title":"PLoS medicine"},{"issue":"3","key":"ref92","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/pro.324","article-title":"Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities","volume":"19","author":"CE Cade","year":"2010","journal-title":"Protein science: a publication of the Protein Society"},{"issue":"9","key":"ref93","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/jac\/dku161","article-title":"Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"69","author":"T Jagielski","year":"2014","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"3","key":"ref94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug-resistant tuberculosis in a Russian population","volume":"46","author":"N Casali","year":"2014","journal-title":"Nature genetics"},{"issue":"6","key":"ref95","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/mmi.12520","article-title":"Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the beta' subunit of RNA polymerase","volume":"91","author":"T Song","year":"2014","journal-title":"Molecular microbiology"},{"issue":"265","key":"ref96","doi-asserted-by":"crossref","first-page":"265ra166","DOI":"10.1126\/scitranslmed.3009501","article-title":"PET\/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis","volume":"6","author":"RY Chen","year":"2014","journal-title":"Science translational medicine"},{"issue":"1","key":"ref97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/emph\/eot003","article-title":"Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis","volume":"2013","author":"S Borrell","year":"2013","journal-title":"Evolution, medicine, and public health"},{"issue":"2","key":"ref98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tube.2006.06.001","article-title":"Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages","volume":"87","author":"S Chanwong","year":"2007","journal-title":"Tuberculosis"},{"issue":"3","key":"ref99","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2006.12.001","article-title":"Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein","volume":"87","author":"RC Hartkoorn","year":"2007","journal-title":"Tuberculosis"},{"issue":"7","key":"ref100","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.47.7.2118-2124.2003","article-title":"Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis","volume":"47","author":"R Jayaram","year":"2003","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"8","key":"ref101","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/AAC.48.8.2951-2957.2004","article-title":"Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis","volume":"48","author":"R Jayaram","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref102","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dku457","article-title":"Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents","volume":"70","author":"SB Lakshminarayana","year":"2015","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"10","key":"ref103","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"B Prideaux","year":"2015","journal-title":"Nature medicine"},{"issue":"12","key":"ref104","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkq374","article-title":"Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis","volume":"65","author":"JE de Steenwinkel","year":"2010","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"20","key":"ref105","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMc1505196","article-title":"Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis","volume":"373","author":"GV Bloemberg","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref106","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01719-2016","article-title":"Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors","volume":"49","author":"N Veziris","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"ref107","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JCM.00330-06","article-title":"Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam","volume":"44","author":"M Caws","year":"2006","journal-title":"Journal of clinical microbiology"},{"issue":"5","key":"ref108","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3201\/eid1205.041339","article-title":"Mycobacterium tuberculosis and rifampin resistance, United Kingdom","volume":"12","author":"IC Sam","year":"2006","journal-title":"Emerging infectious diseases"},{"issue":"3","key":"ref109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/rr54","article-title":"The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis","volume":"2","author":"A Somoskovi","year":"2001","journal-title":"Respir Res"},{"issue":"1","key":"ref110","doi-asserted-by":"crossref","first-page":"e02537","DOI":"10.1128\/mBio.02537-14","article-title":"Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model","volume":"6","author":"E Guirado","year":"2015","journal-title":"mBio"},{"issue":"104","key":"ref111","doi-asserted-by":"crossref","DOI":"10.3791\/53084","article-title":"A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection","author":"C Braian","year":"2015","journal-title":"J Vis Exp"},{"issue":"1","key":"ref112","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02073-16","article-title":"A Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address Antimicrobial Resistance in Tuberculosis","volume":"8","author":"MK Bielecka","year":"2017","journal-title":"mBio"},{"issue":"3","key":"ref113","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx020","article-title":"Relapse, re-infection and mixed infections in tuberculosis disease","volume":"75","author":"A McIvor","year":"2017","journal-title":"Pathog Dis"},{"issue":"3","key":"ref114","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10096-007-0257-9","article-title":"Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children","volume":"26","author":"HS Schaaf","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"suppl_1","key":"ref115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ofid\/ofw172.422","article-title":"Treatment Outcomes in Low-Level Isoniazid Resistant Tuberculosis","volume":"3","author":"A Isaac","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"key":"ref116","article-title":"A Dose Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis","author":"MJ Boeree","year":"2015","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"8","key":"ref117","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.5588\/ijtld.11.0198","article-title":"High-dose rifampicin: how do we proceed?","volume":"15","author":"MJ Boeree","year":"2011","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"17","key":"ref118","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-dose rifapentine with moxifloxacin for pulmonary tuberculosis","volume":"371","author":"A Jindani","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref119","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(16)30274-2","article-title":"High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial","volume":"17","author":"MJ Boeree","year":"2017","journal-title":"The Lancet Infectious diseases"},{"issue":"11","key":"ref120","doi-asserted-by":"crossref","first-page":"e0142384","DOI":"10.1371\/journal.pone.0142384","article-title":"Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study","volume":"10","author":"N Chida","year":"2015","journal-title":"PLoS One"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/1471-2458-11-696","article-title":"Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study","volume":"11","author":"BN Muture","year":"2011","journal-title":"BMC Public Health"},{"issue":"4","key":"ref122","doi-asserted-by":"crossref","first-page":"e93574","DOI":"10.1371\/journal.pone.0093574","article-title":"Treatment default amongst patients with tuberculosis in urban Morocco: predicting and explaining default and post-default sputum smear and drug susceptibility results","volume":"9","author":"I Cherkaoui","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ref123","first-page":"CD006591","article-title":"Patient education and counselling for promoting adherence to treatment for tuberculosis","author":"JM M'Imunya","year":"2012","journal-title":"The Cochrane database of systematic reviews"},{"issue":"12","key":"ref124","first-page":"1081","article-title":"Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa","volume":"3","author":"C Connolly","year":"1999","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"2","key":"ref125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020341","article-title":"Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review","volume":"18","author":"GB Migliori","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref126","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7403.1","article-title":"Current strategies to treat tuberculosis","volume":"5","author":"AT Podany","year":"2016","journal-title":"F1000Res"},{"issue":"6","key":"ref127","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12195-017-0507-6","article-title":"Applying Optimization Algorithms to Tuberculosis Antibiotic Treatment Regimens","volume":"10","author":"JM Cicchese","year":"2017","journal-title":"Cellular and Molecular Bioengineering"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T06:49:25Z","timestamp":1661237365000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196322"}},"subtitle":[],"editor":[{"given":"Pere-Joan","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":127,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196322","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}